Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Hepatitis

Free Subscription Articles published in Gut Retrieve available abstracts of 62 articles: HTML format

Single Articles

July 2008
1. GUIDO M , Bortolotti F
   Chronic viral hepatitis in children: any role for the pathologist?
   Gut. 2008;57:873-7.
   PubMed     Related articles   
   
   
   May 2008
2. PLANCOULAINE S , Mohamed MK, Arafa N, Bakr I, et al
   Dissection of familial correlations in Hepatitis C Virus (HCV) seroprevalence suggests evidence for intrafamilial viral transmission and genetic predisposition to infection.
   Gut. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. JONES M , Owen JS
   How does interferon inhibit HCV cell entry?
   Gut. 2008;57:573-4.
   PubMed     Related articles   
   
   
   
4. MARRA F
   Nuclear factor-kappaB inhibition and non-alcoholic steatohepatitis: inflammation as a target for therapy.
   Gut. 2008;57:570-2.
   PubMed     Related articles   
   
   
   April 2008
5. PINZANI M , Arena U, Vizzutti F, Abraldes J, et al
   Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C.
   Gut. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. STARKEL P
   Genetic factors predicting response to interferon treatment for viral hepatitis C.
   Gut. 2008;57:440-2.
   PubMed     Related articles   
   
   
   March 2008
7. GOLDEN-MASON L , Madrigal-Estebas L, McGrath E, Conroy MJ, et al
   Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
   Gut. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. TARGHER G , Zoppini G, Muggeo M
   Differential relationships between basal and post-load insulin resistance indices and hepatic fibrosis in chronic hepatitis C and in non-alcoholic fatty liver disease.
   Gut. 2008;57:426.
   PubMed     Related articles   
   
   
   January 2008
9. RIGAMONTI C , Donato MF, Fraquelli M, Agnelli F, et al
   Transient elastography predicts fibrosis progression in patients with recurrent hepatitis c after liver transplantation.
   Gut. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. DE MITRI MS , Bernardi M
    Predicting the development of hepatocellular cancer in hepatitis B carriers.
    Gut. 2008;57:12-5.
    PubMed     Related articles   
    
    
    December 2007
11. KRAUS MR , Schafer A, Schottker K, Keicher C, et al
    Therapy of interferon-induced depression in chronic hepatitis C with citalopram: A randomized, double-blind, placebo-controlled study.
    Gut. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
12. POUPON R , Serfaty L
    Ursodeoxycholic acid in chronic hepatitis C.
    Gut. 2007;56:1652-3.
    PubMed     Related articles   
    
    
    November 2007
13. PAPATHEODORIDIS GV , Hadizyannis E, Tsochatzis E, Chrysanthos N, et al
    Serum Apoptotic Caspase Activity As A Marker Of Severity In Hbeag-Negative Chronic Hepatitis B Virus Infection.
    Gut. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
14. MURAO K , Imachi H, Yu X, Cao WM, et al
    Interferon-{alpha} decreases expression of human scavenger receptor class BI, possible HCV receptor in hepatocytes.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
15. FLINK HJ , Buster EH, Merican I, Nevens F, et al
    Relapse after treatment with peginterferon {alpha}-2b alone or in combination with lamivudine in HBeAg positive chronic hepatitis B.
    Gut. 2007;56:1485-1486.
    PubMed     Related articles   
    
    
    
16. PERSICO E , De Renzo A, La Mura V, Bruno S, et al
    Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients.
    Gut. 2007;56:1470-1.
    PubMed     Related articles   
    
    
    
17. WATANABE T , Katsukura H, Chiba T, Kita T, et al
    Periportal and sinusoidal liver dendritic cells suppressing T helper type 1-mediated hepatitis.
    Gut. 2007;56:1445-51.
    PubMed     Related articles    Abstract available
    
    
    
18. NOUN R , Zeidan S, Ghorra C, Slaba S, et al
    Jaundice in a chronic hepatitis B carrier.
    Gut. 2007;56:1409.
    PubMed     Related articles   
    
    
    September 2007
19. ASSELAH T , Bieche I, Narguet S, Sabbagh A, et al
    Liver Gene Expression Signature to Predict Response to Pegylated interferon plus Ribavirin combination therapy in Patients with Chronic Hepatitis C.
    Gut. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
20. PERSICO M , Capasso M, Russo R, Persico E, et al
    Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.
    Gut. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
21. LIU CH , Liang CC, Lin JW, Chen SI, et al
    Pegylated Interferon Alfa-2a versus Standard Interferon Alfa-2a for Treatment-Naive Dialysis Patients with Chronic Hepatitis C: A Randomized Study.
    Gut. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
22. OBEN JA , Paulon E
    Fatty liver in chronic hepatitis C infection: unravelling the mechanisms.
    Gut. 2007;56:1186-8.
    PubMed     Related articles   
    
    
    
23. JAMIL KM , Hagan TV, Trotter J, Cheng W, et al
    Editor's quiz: Acute liver failure in a patient with lung cancer.
    Gut. 2007;56:1190.
    PubMed     Related articles   
    
    
    August 2007
24. FATTOVICH G , Olivari N, Pasino M, D'Onofrio M, et al
    Long-term outcome of chronic hepatitis B in caucasian patients: mortality after 25 years.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. DAHABA AA , Worm HC, Zhu SM, Bao FP, et al
    Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy. A multicentre, observer-blinded, validation study.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. DAI CY , Huang JF, Hsieh MY, Lee LP, et al
    Links between triglyceride levels, hepatitis C virus infection and diabetes.
    Gut. 2007;56:1167-8.
    PubMed     Related articles   
    
    
    
27. RYDER S
    Do high lipids help clearance of hepatitis C?
    Gut. 2007;56:1044-5.
    PubMed     Related articles   
    
    
    July 2007
28. FORREST EH , Morris J, Stewart S, Phillips M, et al
    The Glasgow Alcoholic Hepatitis Score Identifies Patients Who May Benefit From Corticosteroids.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
29. VELDHUIJZEN IK , Mostert MC, Niesters HG, Richardus JH, et al
    Accuracy of a referral guideline for patients with chronic hepatitis B in primary care to select patients eligible for evaluation by a specialist.
    Gut. 2007;56:1027-8.
    PubMed     Related articles   
    
    
    
30. HOLT AP , Adams DH
    Complex roles of cyclo-oxygenase 2 in hepatitis.
    Gut. 2007;56:903-4.
    PubMed     Related articles   
    
    
    
31. CHAKASS D , Philippe D, Erdual E, Dharancy S, et al
    micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.
    Gut. 2007;56:974-81.
    PubMed     Related articles    Abstract available
    
    
    
32. FRAQUELLI M , Rigamonti C, Casazza G, Conte D, et al
    Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease.
    Gut. 2007;56:968-73.
    PubMed     Related articles    Abstract available
    
    
    June 2007
33. OMATA M , Yoshida H, Toyota J, Tomita E, et al
    A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.
    Gut. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
34. STROFFOLINI T , Rapicetta M, Di Stefano R, Bakr I, et al
    Hepatitis C virus clearance and gender * Authors' response.
    Gut. 2007;56:884.
    PubMed     Related articles   
    
    
    May 2007
35. UMEMURA T , Zen Y, Hamano H, Ichijo T, et al
    IgG4-associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. CHOU YC , Yu MW, Wu CF, Yang SY, et al
    Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. DUSHEIKO G , Antonakopoulos N
    Treatment of hepatitis B.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. YUEN MF , Tanaka Y, Shinkai N, Poon RT, et al
    Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/ C, specific mutations of enhancer II/ core promoter/ precore regions and HBV DNA levels.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. KUMADA T , Toyoda H, Kiriyama S, Sone Y, et al
    Relation between incidence of hepatic carcinogenesis and integration value of alanine aminotransferase in patients with hepatitis C virus infection.
    Gut. 2007;56:738-9.
    PubMed     Related articles   
    
    
    
40. DAI CY , Huang JF, Hsieh MY, Lee LP, et al
    The role of gender on clearance of hepatitis C virus: a different story in an area endemic for hepatitis B and C.
    Gut. 2007;56:737-8.
    PubMed     Related articles   
    
    
    
41. THURSZ M
    Iron, haemochromatosis and thalassaemia as risk factors for fibrosis in hepatitis C virus infection.
    Gut. 2007;56:613-614.
    PubMed     Related articles   
    
    
    March 2007
42. SVEGLIATI-BARONI G , Bugianesi E, Bousheral T, Ridolfi F, et al
    Post-load insulin resistance is an independent predictor of hepatic fibrosis in Virus C Chronic Hepatitis and in Nonalcoholic Fatty Liver Disease.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. PAYAN C , Pivert A, Morand P, Fafi-Kremer S, et al
    Rapid and early virological response to chronic Hepatitis C treatment with IFN alpha-2b or PEG- IFN alpha-2b plus ribavirin in HIV/HCV co-infected patients.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. EL-ZAYADI AR , Attia ME, Barakat EM, Zalata K, et al
    Non-alcoholic fatty liver disease in hcv-genotype 4 patients.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. NEAL K , Irving WL
    Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. TROJAN J , Stuermer M, Teuber G, Berger A, et al
    Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer? * Authors' response.
    Gut. 2007;56:436-7.
    PubMed     Related articles   
    
    
    
47. ZHAI Y , Qiu W, Dong XJ, Zhang XM, et al
    Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk.
    Gut. 2007;56:445-7.
    PubMed     Related articles   
    
    
    February 2007
48. WATSON J , Graves S, Ferguson J, D'Este C, et al
    Hepatitis C virus RNA quantitation and degradation studies in whole blood samples in vitro.
    Gut. 2007;56:306-7.
    PubMed     Related articles   
    
    
    
49. SINGH G , Palaniappan S, Rotimi O, Hamlin PJ, et al
    Autoimmune hepatitis triggered by hepatitis A.
    Gut. 2007;56:304.
    PubMed     Related articles   
    
    
    January 2007
50. HOURIOUX C , Patient R, Morin A, Blanchard E, et al
    The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model.
    Gut. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
51. YU J , Hui AY, Chu ES, Cheng AS, et al
    Expression of a COX-2 Transgene in Murine Liver Causes Hepatitis.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
52. CHOLONGITAS E , Quaglia A, Samonakis D, Senzolo M, et al
    Transjugular liver biopsy: how good is it for accurate histological interpretation?
    Gut. 2006;55:1789-94.
    PubMed     Related articles    Abstract available
    
    
    November 2006
53. SARTORI M , Andorno S, Pagliarulo M, Rigamonti C, et al
    Heterozygous {beta} -globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis c.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
54. BONINO F , Marcellin P, Lau GK, Hadziyannis S, et al
    Predicting response to peginterferon alfa-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
55. FORTON DM
    Altered monoaminergic transporter binding in hepatitis C related cerebral dysfunction: a neuroimmunologial condition?
    Gut. 2006;55:1535-1537.
    PubMed     Related articles   
    
    
    
56. WATANABE T , Inoue M, Harada K, Homma N, et al
    A case of exacerbation of ulcerative colitis induced by combination therapy with PEG-interferon {alpha}-2b and ribavirin.
    Gut. 2006;55:1682-3.
    PubMed     Related articles   
    
    
    
57. COBBOLD JF , Wylezinska M, Cunningham C, Crossey ME, et al
    Non-invasive evaluation of hepatic fibrosis using magnetic resonance and ultrasound techniques * Author's reply.
    Gut. 2006;55:1670.
    PubMed     Related articles   
    
    
    
58. ARMENDARIZ-BORUNDA J , Islas-Carbajal MC, Meza-Garcia E, Rincon AR, et al
    A pilot study in patients with established advanced liver fibrosis using pirfenidone.
    Gut. 2006;55:1663-5.
    PubMed     Related articles   
    
    
    September 2006
59. BUTT AA , Justice AC, Skanderson M, Rigsby M, et al
    Rate and predictors of treatment prescription for hepatitis C.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
60. CODES L , Asselah T, Cazals-Hatem D, Tubach F, et al
    Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of menopause and steatosis and the potential benefit of hormone replacement therapy.
    Gut. 2006;.
    PubMed     Related articles    Abstract available
    
    
    March 2006
61. HARCOURT G , Gomperts E, Donfield S, Klenerman P, et al
    Profound loss of HCV-specific interferon-gamma secreting CD4+ T cells in HIV/HCV co-infected patients.
    Gut. 2006;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
62. FRELIN L , Brenndorfer ED, Ahlen G, Weiland M, et al
    The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour- necrosis factor-a-mediated liver disease.
    Gut. 2006;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: